Literature DB >> 22426148

The impact of race and comorbidity on survival in endometrial cancer.

Sara H Olson1, Coral L Atoria, Michele L Cote, Linda S Cook, Radhai Rastogi, Robert A Soslow, Carol L Brown, Elena B Elkin.   

Abstract

BACKGROUND: Poorer survival from endometrial cancer in blacks than in whites is well documented. The aims of this study were to determine whether diabetes, hypertension, or other conditions influence survival and whether accounting for these conditions reduces this racial disparity.
METHODS: Using the SEER-Medicare database, we investigated the influence of diabetes, hypertension, and other comorbid conditions on survival in black and white women age ≥66 with endometrial cancer. We used Cox proportional hazards regression to evaluate the influence of comorbidities on survival for blacks and whites separately and to study survival differences between blacks and whites after adjustment for diabetes, hypertension, and other medical conditions, as well as for demographics, tumor characteristics, and treatment.
RESULTS: In both racial subgroups, women with diabetes or other conditions had poorer overall survival, whereas hypertensive black women experienced better survival [HR, 0.74; 95% confidence interval (CI), 0.60-0.92]. For disease-specific survival, diabetes was associated with poorer survival in white women (HR, 1.19; 95% CI, 1.06-1.35) but not in blacks (HR, 0.97; 95% CI, 0.73-1.30); hypertension and other conditions were not significantly related to survival. After adjustment, black women had poorer survival than white women, with HRs of 1.16 (95% CI, 1.05-1.28) for overall and 1.27 (95% CI, 1.08-1.49) for disease-specific survival.
CONCLUSIONS: Diabetes influences disease-specific survival in white women but not in blacks. The racial disparity in survival is not explained by the presence of other health conditions. IMPACT: Further research should focus on the unknown factors that lead to poorer survival in black women compared with whites.

Entities:  

Mesh:

Year:  2012        PMID: 22426148     DOI: 10.1158/1055-9965.EPI-11-0735

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  30 in total

1.  Response to an exercise intervention after endometrial cancer: differences between obese and non-obese survivors.

Authors:  K Basen-Engquist; C Carmack; J Brown; A Jhingran; G Baum; J Song; S Scruggs; M C Swartz; M G Cox; K H Lu
Journal:  Gynecol Oncol       Date:  2014-04       Impact factor: 5.482

2.  Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.

Authors:  Ashley S Felix; Eric M McLaughlin; Bette J Caan; David E Cohn; Garnet L Anderson; Electra D Paskett
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

3.  The influence of comorbid conditions on racial disparities in endometrial cancer survival.

Authors:  Julie J Ruterbusch; Rouba Ali-Fehmi; Sara H Olson; Shawnita Sealy-Jefferson; Benjamin A Rybicki; Sharon Hensley-Alford; Mohamed A Elshaikh; Arthur R Gaba; Daniel Schultz; Adnan R Munkarah; Michele L Cote
Journal:  Am J Obstet Gynecol       Date:  2014-06-19       Impact factor: 8.661

Review 4.  Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.

Authors:  Yvonne Collins; Kevin Holcomb; Eloise Chapman-Davis; Dineo Khabele; John H Farley
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

5.  History of uterine leiomyoma and risk of endometrial cancer in black women.

Authors:  Lauren A Wise; Todd R Sponholtz; Lynn Rosenberg; Lucile L Adams-Campbell; Wendy Kuohung; Michael P LaValley; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2016-02-29       Impact factor: 2.506

6.  Impact of age at diagnosis on racial disparities in endometrial cancer patients.

Authors:  Christopher M Tarney; Chunqiao Tian; Guisong Wang; Elizabeth A Dubil; Nicholas W Bateman; John K Chan; Mohamed A Elshaikh; Michele L Cote; Joellen M Schildkraut; Craig D Shriver; Thomas P Conrads; Chad A Hamilton; G Larry Maxwell; Kathleen M Darcy
Journal:  Gynecol Oncol       Date:  2017-08-08       Impact factor: 5.482

7.  Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients.

Authors:  Hannah Arem; Yikyung Park; Colleen Pelser; Rachel Ballard-Barbash; Melinda L Irwin; Albert Hollenbeck; Gretchen L Gierach; Louise A Brinton; Ruth M Pfeiffer; Charles E Matthews
Journal:  J Natl Cancer Inst       Date:  2013-01-07       Impact factor: 13.506

8.  Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013.

Authors:  XueLian Li; SaiHua Zheng; ShangJie Chen; Feng Qin; Sandy Lau; Qi Chen
Journal:  Tumour Biol       Date:  2015-02-04

Review 9.  Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.

Authors:  B Long; F W Liu; R E Bristow
Journal:  Gynecol Oncol       Date:  2013-05-23       Impact factor: 5.482

10.  Limited utility despite accuracy of the national SEER dataset for the study of craniopharyngioma.

Authors:  Todd C Hankinson; Emma C Fields; Michelle R Torok; Brenda L Beaty; Michael H Handler; Nicholas K Foreman; Brent R O'neill; Arthur K Liu
Journal:  J Neurooncol       Date:  2012-08-23       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.